A trade group representing pharmacy benefit managers asked the U.S. Supreme Court not to review a case asking whether an Arkansas law regulating how companies like
The case is a “poor vehicle” for addressing how state drug pricing laws interact with the federal Employee Retirement Income Security Act, the Pharmaceutical Care Management Association told the justices in a Feb. 28 brief. The decision below—in which the U.S. Court of Appeals for the Eighth Circuit struck down the Arkansas law as ERISA-preempted—was “opaque” in its ...